Cargando…
Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003511/ https://www.ncbi.nlm.nih.gov/pubmed/27601884 http://dx.doi.org/10.2147/DDDT.S115852 |
| _version_ | 1782450662016024576 |
|---|---|
| author | Abdel-Razeq, Hikmat Mansour, Asem |
| author_facet | Abdel-Razeq, Hikmat Mansour, Asem |
| author_sort | Abdel-Razeq, Hikmat |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5003511 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Dove Medical Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-50035112016-09-06 Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients Abdel-Razeq, Hikmat Mansour, Asem Drug Des Devel Ther Letter Dove Medical Press 2016-08-24 /pmc/articles/PMC5003511/ /pubmed/27601884 http://dx.doi.org/10.2147/DDDT.S115852 Text en © 2016 Abdel-Razeq and Mansour. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
| spellingShingle | Letter Abdel-Razeq, Hikmat Mansour, Asem Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title | Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title_full | Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title_fullStr | Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title_full_unstemmed | Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title_short | Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| title_sort | fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003511/ https://www.ncbi.nlm.nih.gov/pubmed/27601884 http://dx.doi.org/10.2147/DDDT.S115852 |
| work_keys_str_mv | AT abdelrazeqhikmat fondaparinuxvswarfarinforthetreatmentofunsuspectedpulmonaryembolismincancerpatients AT mansourasem fondaparinuxvswarfarinforthetreatmentofunsuspectedpulmonaryembolismincancerpatients |